Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-016988

Options or other derivatives

  • SVP, General Counsel acquired 202,704 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Manzano Stephen SVP, General Counsel 2021-03-01 Grant or award · Restricted Stock Units +67,568 67,568 D
Manzano Stephen SVP, General Counsel 2021-03-01 Grant or award · Performance-Based Restricted Stock Units +135,136 135,136 D
Loading xslF345X03/doc4.xml…